Search Results - "Bani Sadr, F."

Editorial: diabetes in HIV‐infected patients—do not blame the usual suspect! Authors’ reply by Provoost, A., Dramé, M., Bani‐Sadr, F.

“…Linked Content This article is linked to Provoost et al and Höner zu Siederdissen and Mederacke papers. To view these articles visit…”
Get full text

Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study by Gantner, P, Pugliese, P, Bani‐Sadr, F, Joly, V, Poizot‐Martin, I, Garraffo, R, Peytavin, G, Fafi‐Kremer, S, Rey, D, Bonnet, B., Bouchez, S., Hall, N., Aubry, O., Point, P., Besnier, M., Grossi, O., Lefebvre, M., Hüe, H., Soria, A., Pineau, S., André‐Garnier, E., Rodallec, A., Brégigeon, S., Faucher, O., Orticoni, M., Soavi, M. J., Ressiot, E., Pinot, I., Ducassou, M. J., Bertone, H., Gallie, S., Ritleng, A. S., Ivanova, A., Blanco‐Betancourt, C., Alvarez, M., Biezunski, N., Debard, A., Delobel, P., Delpierre, C., Marchou, B., Martin‐Blondel, G., Mularczyk, M., Garipuy, D., Saune, K., Marcel, M., Puntis, E., Ceppi, C., Cottalorda, J., Dellamonica, P., Demonchy, E., Dunais, B., Ferrando, S., Fuzibet, J. G., Risso, K., Mondain, V., Naqvi, A., Oran, N., Perbost, I., Pillet, S., Prouvost‐Keller, B., Wehrlen‐Pugliese, S., Rosenthal, E., Roger, P. M., Vandame, S., Ajana, F., Baclet, V., Huleux, T. H., Melliez, H., Viget, N., Aissi, E., Meybeck, A., Agher, R., Katlama, C., Mackoumbou‐Nkouka, C., Louni, F., Descamps, D., Cotte, L., Peyramond, D., Chidiac, C., Ader, F., Biron, F., Boibieux, A., Miailhes, P., Perpoint, T., Dahoud, F., Lippmann, J., Koffi, J., Longuet, C., Guéripel, V., Augustin‐Normand, C., Degroodt, S., Batard, M. L., Cheneau, C., Mautort, E., Fischer, P., Partisani, M., Priester, M., Bani‐Sadr, F., Berger, J. L., Hentzien, M.

Get full text

Impact of age-related comorbidities on five-year overall mortality among elderly HIV-infected patients in the late HAART era — Role of chronic renal disease by Hentzien, Maxime, Dramé, M., Allavena, C., Jacomet, C., Valantin, M.-A., Cabié, A., Cuzin, L., Rey, D., Pugliese, P., Bani-Sadr, F.

“…Objectives To identify main prognostic factors for 5-year mortality among age-related comorbidities (ARCs) in older people living with HIV (PLHIV). Design A…”
Get full text

Risk of diabetes in HIV‐infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort by Provoost, A., Dramé, M., Cotte, L., Cuzin, L., Garraffo, R., Rey, D., Raffi, F., Poizot‐Martin, I., Pugliese, P., Enel, P., Obry‐Roguet, V., Faucher, O., Bregigeon, S., Ménard, A., Biezunski, N., Cuzin, L., Delobel, P., Fourcade, C., Porte, L., Mularczyk, M., Garipuy, D., Lepain, I., Marcel, M., Metsu, D., Puntis, E., Pugliese, P., Ceppi, C., Cottalorda, J., Ferrando, S., Fuzibet, J. G., Garraffo, R., Naqvi, A., Perbost, I., Pillet, S., Prouvost‐Keller, B., Pradier, C., Roger, P. M., Rosenthal, E., Dellamonica, P., Raffi, F., Bonnet, B., Brunet, C., Jovelin, T., Bernaud, C., Morineau, P., Reliquet, V., Hüe, H., Cavellec, M., Soria, A., André‐Garnier, E., Rodallec, A., Ferré, V., Leguen, L., Lefebvre, M., Jacomet, C., Cheret, A., Choisy, P., Duvivier, C., Valantin, M. A., Agher, R., Katlama, C., Isnard‐Bagnis, C., Peytavin, G., Joly, V., Yazdanpanah, Y., Cabié, A., Pierre‐François, S., Liautaud, B., Fischer, P., Cheneau, C., Priester, M., Bernard‐Henry, C., de Mautort, E., May, T., Hoen, B., Chirouze, C., Gardiennet, Q., Bani‐Sadr, F., Berger, J. L., N'Guyen, Y., Lambert, D., Lebrun, D., Kmiec, I., Brodard, V., Cotte, L., Chidiac, C., Ferry, T., Ader, F., Biron, F., Boibieux, A., Miailhes, P., Perpoint, T., Schlienger, I., Braun, E., Koffi, J., Longuet, C., Guéripel, V., Augustin‐Normand, C., Degroodt, S., Peyramond, D.

“…Summary Background Both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections have been reportedly associated with a higher risk of…”
Get full text

Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients by Loko, M.-A., Bani-Sadr, F., Winnock, M., Lacombe, K., Carrieri, P., Neau, D., Morlat, P., Serfaty, L., Dabis, F., Salmon, D.

“…The impact of antiretroviral drug exposure and associated lipodystrophy and/or insulin resistance (IR) on advanced liver fibrosis in HIV/HCV‐coinfected…”
Get full text

Ninety-Six—Week Efficacy of Combination Therapy with Lamivudine and Tenofovir in Patients Coinfected with HIV-1 and Wild-Type Hepatitis B Virus by Bani-Sadr, F., Palmer, P., Scieux, C., Molina, J. M.

“…We describe 6 patients who were coinfected with human immunodeficiency virus (HIV) type 1 and wild-type hepatitis B virus (HBV), in whom complete and sustained…”
Get full text

Comparative risk of failure of ABC/3TC or TDF/FTC based first‐line regimens in patients with a high viral load by Flandre, P, Pugliese, P, Allavena, C, Katlama, C, Cotte, L, Cheret, A, Cabié, A, Rey, D, Chirouze, C, Cuzin, L, Obry‐Roguet, V., Bregigeon, S., Poizot‐Martin, I., Marchou, B., Massip, P., Bonnet, E., Obadia, M., Alvarez, M., Porte, L., Delobel, P., Chauveau, M., Garipuy, D., Bernard, J., Lepain, I., Marcel, M., Puntis, E., Sauné, K., Ceppi, C., Cua, E., Cottalorda, J., Dellamonica, P., Demonchy, E., Durant, J., Etienne, C., Ferrando, S., Garraffo, R., Mondain, V., Oran, N., Perbost, I., Pillet, S., Prouvost‐Keller, B., Pradier, C., Wehrlen‐Pugliese, S., Sausse, S., Roger, P.M., Bernaud, C., Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Boutoille, D., Hall, N., Jovelin, T., Morineau, P., Reliquet, V., Hue, H., Larmet, L., Pineau, So, Ferré, V., André‐Garnier, E., Rodallec, A., Choisy, P., Yazdanpanah, Y., Landman, R., Duvivier, C., Agher, R., Consigny, P.H., Cessot, G., Touam, F., Usubillaga, R., Benhadj, K., Abel, S., Pierre‐François, S., Ouka, M., Martial, J., Ebel, E., Cheneau, C, Priester, M, Batard, ML, Bernard‐Henry, C, Mautort, E, Drobacheff‐Thiébaut, C., Faller, J.P., Faucher, J.F., Foltzer, A., Jacomet, C., Laurichesse, H., Lesens, O., Aumeran, C., Baud, O., Beytout, J., Coban, D., Casanova, S., Rouger, C., Peyramond, D., Chidiac, C., Ader, F., Boibieux, A., Miailhes, P, Perpoint, T.

“…Objectives To compare the efficacy, in current clinical practice, of first regimens containing abacavir with lamivudine (ABC/3TC) or tenofovir with…”
Get full text

Factors associated with guideline‐based hepatitis C virus (HCV) treatment initiation in HIV/HCV‐coinfected patients: role of comorbidities and physicians' perceptions by Winnock, M, Bani‐Sadr, F, Pambrun, E, Loko, M‐A, Carrieri, P, Neau, D, Morlat, P, Marchou, B, Dabis, F, Salmon, D

“…Objectives Many HIV‐infected patients with chronic hepatitis C virus (HCV) infection do not receive treatment for HCV infection, often because of…”
Get full text

Severe transaminitis after interferon-ribavirin therapy in HIV/HCV-coinfected patients: influence of a sustained HCV response by Bani-Sadr, F., Krastinova, E., Fromentin, D., Piroth, L., Rosenthal, E., Quertainmont, Y., Perronne, C., Cacoub, P., Pol, S., Carrat, F.

“…Chronic hepatitis C is an independent risk factor for severe drug hepatotoxicity. Successful treatment of chronic hepatitis C may modulate drug hepatotoxicity,…”
Get full text

Acute Coxsackievirus B3-induced meningo-cerebellitis in an immunocompetent adult patient by Chung, M., Andreoletti, L., N’Guyen, Y., Soize, S., Bani-Sadr, F., Hentzien, M.

“…We report an acute Coxsackievirus B3 (CVB3)-induced meningo-cerebellitis in an immunocompetent adult patient. CVB3 has a global distribution and is the most…”
Get full text

Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors by Bani-Sadr, F., Lapidus, N., Melchior, J.-C., Ravaux, I., Bensalem, M., Rosa, I., Cacoub, P., Pol, S., Perronne, C., Carrat, F.

“…Weight loss is reported by more than 20% of hepatitis C virus (HCV)‐monoinfected patients treated with the peg‐interferon (peg‐IFN) and ribavirin combination…”
Get full text

Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin by Bani-Sadr, F., Goderel, I., Penalba, C., Billaud, E., Doll, J., Welker, Y., Cacoub, P., Pol, S., Perronne, C., Carrat, F.

“…The most frequent and the most troublesome adverse effect of interferon plus ribavirin‐based therapy is anaemia. The aim of this analysis was to determine the…”
Get full text

Chronic hepatitis delta cirrhosis cured by adapting PEG-IFNα-2a + tenofovir disoproxil fumarate treatment duration until HBsAg loss by Yaici, L., Gatouillat, G., Andreoletti, L., N'Guyen, Y., Hentzien, M., Gordien, E., Bani-Sadr, F.

“…As the loss of HBsAg during treatment of chronic hepatitis delta (CHD) is mandatory for definitive clearance and durable response, the optimal target of…”
Get full text

Aseptic splenic abscesses as the inaugural manifestation of Crohn's disease by Favarel-Garrigues, M., Cadiot, G., Bermejo, M., Boulagnon-Rombi, C., Bani-Sadr, F., Hentzien, M.

Get full text

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death by Chalouni, Mathieu, Pol, Stanislas, Sogni, Philippe, Fontaine, Hélène, Lacombe, Karine, Marc-Lacombe, Jean, Esterle, Laure, Dorival, Celine, Bourlière, Marc, Bani-Sadr, Firouzé, de Ledinghen, Victor, Zucman, David, Larrey, Dominique, Salmon, Dominique, Carrat, Fabrice, Wittkop, Linda, Salmon, D., Wittkop, L., Sogni, P., Esterle, L., Trimoulet, P., Izopet, J., Serfaty, L., Paradis, V., Spire, B., Carrieri, P., Valantin, M.A., Pialoux, G., Chas, J., Poizot-Martin, I., Barange, K., Naqvi, A., Rosenthal, E., Bicart-See, A., Bouchaud, O., Gervais, A., Lascoux-Combe, C., Goujard, C., Lacombe, K., Duvivier, C., Neau, D., Morlat, P., Bani-Sadr, F., Meyer, L., Boufassa, F., Autran, B., Roque, A.M., Solas, C., Fontaine, H., Costagliola, D., Piroth, L., Simon, A., Zucman, D., Boué, F., Miailhes, P., Billaud, E., Aumaitre, H., Rey, D., Peytavin, G., Petrov-Sanchez, V., Lebrasseur-Longuet, D.

“…Direct-acting antivirals (DAA) lead to high sustained virological response (SVR) rates and decrease the risk of disease progression. We compared SVR rates and…”
Get full text

Cerebral venous thrombosis: a rare complication of herpes simplex encephalitis by Vedani, M., Toubas, O., Hentzien, M., Brunet, A., Andreoletti, L., Bani-Sadr, F.

“…We report a case of classic HSE with early neurological relapse 7 days after onset of acyclovir treatment secondary to cerebral venous thrombosis (CVT). The…”
Get full text

Rituximab treatment in seronegative autoimmune autonomic neuropathy and autoimmune autonomic ganglionopathy: Case-report and literature review by Bouxin, M., Schvartz, B., Mestrallet, S., Debrumetz, A., Hentzien, M., Tabary, T., Cohen, R., Nicolas, G., Bani-Sadr, F.

“…Autoimmune autonomic ganglionopathy (AAG) is a rare disease with no well-established treatment. Until recently, AAG could be seropositive (50 to 60% of…”
Get full text

Major 5′terminally deleted enterovirus populations modulate type I IFN response in acute myocarditis patients and in human cultured cardiomyocytes by Glenet, M., N’Guyen, Y., Mirand, A., Henquell, C., Lebreil, A.-L., Berri, F., Bani-Sadr, F., Lina, B., Schuffenecker, I., Andreoletti, L.

“…Major 5′terminally deleted (5′TD) group-B enterovirus (EV-B) populations were identified in heart biopsies of patients with fulminant myocarditis or dilated…”
Get full text

Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient by Hentzien, M., Guihot, A., de Maindreville, Doé, Tabary, T., Brodard, V., Vieillard, V., Adle-Biassette, H., Bani-Sadr, F.

“…In HIV patients, HCV co-infection has been associated with an increased risk of progressive multifocal leukoencephalopathy (PML). Furthermore, PML has also…”
Get full text

Persistently normal alanine aminotransferase levels in HIV/HCV‐coinfected patients: the role of steatosis by Bani‐Sadr, F, Barange, K, Daoud, F, Jacomet, C, Bicart‐See, A, Rosenthal, E, Cacoub, P, Pol, S, Perronne, C, Carrat, F

“…Objective The frequency and significance of, and liver biopsy findings associated with, a persistently normal alanine aminotransferase (ALT) level in…”
Get full text